Bio-Works Technologies AB (ST:BIOWKS) — Market Cap & Net Worth
Market Cap & Net Worth: Bio-Works Technologies AB (BIOWKS)
Bio-Works Technologies AB (ST:BIOWKS) has a market capitalization of $35.62 Million (Skr331.04 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #23275 globally and #440 in its home market, demonstrating a 2.16% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-Works Technologies AB's stock price Skr3.31 by its total outstanding shares 100010822 (100.01 Million). Also see Bio-Works Technologies AB asset portfolio for a full breakdown of the balance sheet.
Bio-Works Technologies AB Market Cap History: 2017 to 2026
Bio-Works Technologies AB's market capitalization history from 2017 to 2026. Data shows change from $102.24 Million to $35.62 Million (-13.71% CAGR). Also see cash flow conversion of Bio-Works Technologies AB for how efficiently the company converts equity into cash flow.
Bio-Works Technologies AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-Works Technologies AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Bio-Works Technologies AB share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.45x
Bio-Works Technologies AB's market cap is 0.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $102.24 Million | $4.95 Million | -$23.66 Million | 20.68x | N/A |
| 2018 | $94.87 Million | $6.56 Million | -$37.95 Million | 14.46x | N/A |
| 2019 | $86.32 Million | $5.57 Million | -$42.11 Million | 15.49x | N/A |
| 2020 | $97.94 Million | $7.23 Million | -$44.55 Million | 13.54x | N/A |
| 2021 | $295.98 Million | $21.91 Million | -$12.94 Million | 13.51x | N/A |
| 2022 | $226.02 Million | $41.32 Million | -$44.95 Million | 5.47x | N/A |
| 2023 | $76.42 Million | $43.90 Million | -$56.82 Million | 1.74x | N/A |
| 2024 | $10.36 Million | $25.46 Million | -$37.36 Million | 0.41x | N/A |
| 2025 | $28.20 Million | $62.50 Million | -$15.25 Million | 0.45x | N/A |
Competitor Companies of BIOWKS by Market Capitalization
Companies near Bio-Works Technologies AB in the global market cap rankings as of September 19, 2026. Review how tangible is Bio-Works Technologies AB's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bio-Works Technologies AB by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #177 globally with a market cap of $135.72 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #366 globally with a market cap of $75.25 Billion USD ( €64.36 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #422 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #545 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Intuitive Surgical Inc | NASDAQ:ISRG | $135.72 Billion | $393.33 |
| #366 | EssilorLuxottica S. A. | PA:EL | $75.25 Billion | €139.00 |
| #422 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €68.50 |
| #545 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Bio-Works Technologies AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Bio-Works Technologies AB's market cap moved from $102.24 Million to $ 35.62 Million, with a yearly change of -13.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr35.62 Million | +26.34% |
| 2025 | Skr28.20 Million | +172.07% |
| 2024 | Skr10.36 Million | -86.44% |
| 2023 | Skr76.42 Million | -66.19% |
| 2022 | Skr226.02 Million | -23.64% |
| 2021 | Skr295.98 Million | +202.20% |
| 2020 | Skr97.94 Million | +13.47% |
| 2019 | Skr86.32 Million | -9.02% |
| 2018 | Skr94.87 Million | -7.21% |
| 2017 | Skr102.24 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Bio-Works Technologies AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.62 Million USD |
| MoneyControl | $35.62 Million USD |
| MarketWatch | $35.62 Million USD |
| marketcap.company | $35.62 Million USD |
| Reuters | $35.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bio-Works Technologies AB
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chr… Read more